S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
TSE:ATE

Antibe Therapeutics (ATE) Earnings Date, Estimates & Call Transcripts

C$0.46
-0.01 (-2.13%)
(As of 10/4/2023 ET)
Compare
Today's Range
C$0.46
▼
C$0.47
50-Day Range
C$0.46
▼
C$0.59
52-Week Range
C$0.41
▼
C$0.69
Volume
28,805 shs
Average Volume
27,899 shs
Market Capitalization
C$24.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsInsider TradesHeadlinesSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 13Estimated
Actual EPS
(Aug. 14)
-C$0.11
Consensus EPS
(Aug. 14)
-C$0.11
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ATE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ATE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Antibe Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20231C($0.09)C($0.09)C($0.09)
20231C($0.09)C($0.09)C($0.09)
Q1 20241C($0.11)C($0.11)C($0.11)
Q2 20242C($0.12)C($0.12)C($0.12)
Q3 20242C($0.12)C($0.08)C($0.10)
Q4 20242C($0.12)C($0.06)C($0.09)
FY 20247C($0.47)C($0.37)C($0.42)
Q1 20251C($0.11)C($0.11)C($0.11)

ATE Earnings Date and Information

Antibe Therapeutics last issued its quarterly earnings results on August 14th, 2023. The reported C($0.11) earnings per share (EPS) for the quarter, hitting the consensus estimate of C($0.11). Antibe Therapeutics has generated C($0.35) earnings per share over the last year (C($0.35) diluted earnings per share). Antibe Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off prior year's report dates.

Antibe Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/13/2023
Estimated)		------- 
8/14/2023Q1 2024C($0.11)C($0.11)-C($0.11)--
6/29/2023Q4 2023C($0.09)C($0.06)+C$0.03C($0.06)--
2/14/2023Q3 2023C($0.12)C($0.08)+C$0.04C($0.08)--
11/14/2022Q2 2023C($0.11)C($0.12)C($0.01)C($0.12)--
8/15/2022Q1 2023C($0.11)C($0.10)+C$0.01C($0.10)--
2/14/2022Q3 2022C($0.16)C($0.10)+C$0.06C($0.11)--
11/16/2021Q2 2022C($0.15)C($0.17)C($0.02)C($0.17)C$2.86 millionC$2.76 million
8/16/2021Q1 2022C($0.17)C($0.13)+C$0.04C($0.13)C$2.20 millionC$2.73 million
6/28/2021Q4 2021C($0.06)C($0.14)C($0.08)C($0.14)C$10.63 millionC$2.95 million
2/12/2021Q3 2021C($0.12)C($0.16)C($0.04)C($0.15)C$2.50 millionC$2.79 million
11/12/2020Q2 2021C($0.10)C($0.20)C($0.10)C($0.20)C$2.28 millionC$2.87 million












Antibe Therapeutics Earnings - Frequently Asked Questions

When is Antibe Therapeutics's earnings date?

Antibe Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off last year's report dates. Learn more on ATE's earnings history.

Did Antibe Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Antibe Therapeutics (TSE:ATE) reported C($0.11) earnings per share (EPS) to hit the analysts' consensus estimate of C($0.11). Learn more on analysts' earnings estimate vs. ATE's actual earnings.

How much revenue does Antibe Therapeutics generate each year?

Antibe Therapeutics (TSE:ATE) has a recorded annual revenue of C$9.71 million.

How much profit does Antibe Therapeutics generate each year?

Antibe Therapeutics (TSE:ATE) has a recorded net income of -C$19.48 million. ATE has generated -C$0.35 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (TSE:ATE) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -